{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T20:58:42Z","timestamp":1794085122683,"version":"4.8.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"European Commission & National Strategic Reference Framework","award":["T2-\u0395\u0394\u039a-03807"],"award-info":[{"award-number":["T2-\u0395\u0394\u039a-03807"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The transmembrane-TNF transgenic mouse, TgA86, has been shown to develop spontaneously peripheral arthritis with signs of axial involvement. To assess similarity to human spondyloarthritis, we performed detailed characterization of the axial, peripheral, and comorbid pathologies of this model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>TgA86 bone pathologies were assessed at different ages using CT imaging of the spine, tail vertebrae, and hind limbs and characterized in detail by histopathological and immunohistochemical analysis. Cardiac function was examined by echocardiography and electrocardiography and bone structural parameters by \u03bcCT analysis. The response of TgA86 mice to either early or late anti-TNF treatment was evaluated clinically, histopathologically, and by \u03bcCT analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>TgA86 mice developed with 100% penetrance spontaneous axial and peripheral pathology which progressed with time and manifested as reduced body weight and body length, kyphosis, tail bendings, as well as\u00a0swollen and distorted hind joints. Whole-body CT analysis at advanced ages revealed bone erosions of sacral and caudal vertebrae as well as of sacroiliac joints and hind limbs and, also, new ectopic bone formation and eventually vertebral fusion. The pathology of these mice highly resembled that of SpA patients, as it evolved through an early inflammatory phase, evident as enthesitis and synovitis in the affected joints, characterized by mesenchymal cell accumulation, and neutrophilic infiltration. Subsequently, regression of inflammation was accompanied by ectopic bone formation, leading to ankylosis. In addition, both systemic bone loss and comorbid heart valve pathology were evident. Importantly, early anti-TNF treatment, similar to clinical treatment protocols, significantly reduced the inflammatory phase of both the axial and peripheral pathology of TgA86 mice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The TgA86 mice develop a spontaneous peripheral and axial biphasic pathology accompanied by comorbid heart valvular dysfunction and osteoporosis, overall reproducing the progression of pathognomonic features of human spondyloarthritis. Therefore, the TgA86 mouse represents a valuable model for deciphering the role of transmembrane TNF in the pathogenic mechanisms of spondyloarthritis and for assessing the efficacy of human therapeutics targeting different phases of the disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13075-020-02327-4","type":"journal-article","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T15:02:54Z","timestamp":1601996574000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Ectopic bone formation and systemic bone loss in a transmembrane TNF-driven model of human spondyloarthritis"],"prefix":"10.1186","volume":"22","author":[{"given":"Eleni","family":"Christodoulou-Vafeiadou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Geka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Ntari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ksanthi","family":"Kranidioti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Argyropoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marietta","family":"Armaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iordanis","family":"Mourouzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantinos","family":"Pantos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maritina","family":"Rouchota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Loudos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Denis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niki","family":"Karagianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1867-3150","authenticated-orcid":false,"given":"George","family":"Kollias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,6]]},"reference":[{"key":"2327_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/art.37829","volume":"65","author":"D Baeten","year":"2013","unstructured":"Baeten D, Breban M, Lories R, Schett G, Sieper J. Are spondylarthritides related but distinct conditions or a single disease with a heterogeneous phenotype? Arthritis Rheum. 2013;65:12\u201320.","journal-title":"Arthritis Rheum"},{"key":"2327_CR2","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.berh.2010.05.005","volume":"24","author":"RJU Lories","year":"2010","unstructured":"Lories RJU, de Vlam K, Luyten FP. Are current available therapies disease-modifying in spondyloarthritis? Best Pract Res Clin Rheumatol. 2010;24:625\u201335.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2327_CR3","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1046\/j.1469-7580.2001.19950503.x","volume":"199","author":"M Benjamin","year":"2001","unstructured":"Benjamin M, McGonagle D. The anatomical basis for disease localisation in seronegative spondyloarthropathy at entheses and related sites. J Anat. 2001;199:503\u201326.","journal-title":"J Anat"},{"key":"2327_CR4","first-page":"1547","volume":"53","author":"JE Paramarta","year":"2014","unstructured":"Paramarta JE, Baeten D. Spondyloarthritis: from unifying concepts to improved treatment. Rheumatol (United Kingdom). 2014;53:1547\u201359.","journal-title":"Rheumatol (United Kingdom)"},{"key":"2327_CR5","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.berh.2018.07.007","volume":"31","author":"RJ Lories","year":"2017","unstructured":"Lories RJ, Haroon N. Evolving concepts of new bone formation in axial spondyloarthritis: insights from animal models and human studies. Best Pract Res Clin Rheumatol. 2017;31:877\u201386.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2327_CR6","first-page":"1","volume":"36","author":"R Terenzi","year":"2018","unstructured":"Terenzi R, Monti S, Tesei G, Carli L. One year in review 2017: spondyloarthritis [Internet]. Clin Exp Rheumatol. 2018;36:1\u201314.","journal-title":"Clin Exp Rheumatol"},{"key":"2327_CR7","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/art.38636","volume":"66","author":"M Breban","year":"2014","unstructured":"Breban M, Araujo LM, Chiocchia G. Editorial: animal models of spondyloarthritis: do they faithfully mirror human disease? Arthritis Rheumatol. 2014;66:1689\u201392.","journal-title":"Arthritis Rheumatol"},{"key":"2327_CR8","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1136\/ard.2005.050963","volume":"65","author":"AWR Van Kuijk","year":"2006","unstructured":"Van Kuijk AWR, Reinders-Blankert P, Smeets TJM, Dijkmans BAC, Tak PP. Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment. Ann Rheum Dis. 2006;65:1551\u20137.","journal-title":"Ann Rheum Dis"},{"key":"2327_CR9","doi-asserted-by":"publisher","first-page":"vi4","DOI":"10.1093\/rheumatology\/key001","volume":"57","author":"D Simone","year":"2018","unstructured":"Simone D, Al Mossawi MH, Bowness P. Progress in our understanding of the pathogenesis of ankylosing spondylitis. Rheumatology (Oxford). 2018;57:vi4\u20139.","journal-title":"Rheumatology (Oxford)"},{"key":"2327_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.molimm.2013.07.016","volume":"57","author":"HS Hreggvidsdottir","year":"2014","unstructured":"Hreggvidsdottir HS, Noordenbos T, Baeten DL. Inflammatory pathways in spondyloarthritis. Mol Immunol. 2014;57:28\u201337.","journal-title":"Mol Immunol"},{"key":"2327_CR11","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1002\/art.39282","volume":"67","author":"E Vieira-Sousa","year":"2015","unstructured":"Vieira-Sousa E, Van Duivenvoorde LM, Fonseca JE, Lories RJ, Baeten DL. Review: animal models as a tool to dissect pivotal pathways driving spondyloarthritis. Arthritis Rheumatol. 2015;67:2813\u201327.","journal-title":"Arthritis Rheumatol"},{"key":"2327_CR12","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/S0140-6736(02)08215-6","volume":"359","author":"J Braun","year":"2002","unstructured":"Braun J, Brandt J, Listing J, Zink A, Alten R, Golder W, et al. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet. 2002;359:1187\u201393.","journal-title":"Lancet"},{"key":"2327_CR13","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1136\/annrheumdis-2012-202245","volume":"72","author":"JE Paramarta","year":"2013","unstructured":"Paramarta JE, De Rycke L, Heijda TF, Ambarus CA, Vos K, Dinant HJ, et al. Efficacy and safety of adalimumab for the treatment of peripheral arthritis in spondyloarthritis patients without ankylosing spondylitis or psoriatic arthritis. Ann Rheum Dis. 2013;72:1793\u20139.","journal-title":"Ann Rheum Dis"},{"key":"2327_CR14","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0140-6736(00)02530-7","volume":"356","author":"PJ Mease","year":"2000","unstructured":"Mease PJ, Goffe BS, Metz J, VanderStoep A, Finck B, Burge DJ. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet. 2000;356:385\u201390.","journal-title":"Lancet"},{"key":"2327_CR15","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nri3834","volume":"15","author":"D Brenner","year":"2015","unstructured":"Brenner D, Blaser H, Mak TW. Regulation of tumour necrosis factor signalling: live or let die. Nat Rev Immunol. 2015;15:362\u201374.","journal-title":"Nat Rev Immunol"},{"key":"2327_CR16","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S1074-7613(00)80038-2","volume":"10","author":"D Kontoyiannis","year":"1999","unstructured":"Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F, Kollias G. Impaired on\/off regulation of TNF biosynthesis in mice lacking TNF AU- rich elements: implications for joint and gut-associated immunopathologies. Immunity. 1999;10:387\u201398.","journal-title":"Immunity"},{"key":"2327_CR17","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.98864","volume":"3","author":"M Sakkou","year":"2018","unstructured":"Sakkou M, Chouvardas P, Ntari L, Prados A, Moreth K, Fuchs H, et al. Mesenchymal TNFR2 promotes the development of polyarthritis and comorbid heart valve stenosis. JCI Insight. 2018;3:e98864.","journal-title":"JCI Insight"},{"key":"2327_CR18","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.1002\/j.1460-2075.1991.tb04978.x","volume":"10","author":"J Keffer","year":"1991","unstructured":"Keffer J, Probert L, Cazlaris H, Georgopoulos S, Kaslaris E, Kioussis D, et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J. 1991;10:4025\u201331.","journal-title":"EMBO J"},{"key":"2327_CR19","first-page":"27","volume":"47","author":"E Douni","year":"1995","unstructured":"Douni E, Akassoglou K, Alexopoulou L, Georgopoulos S, Haralambous S, Hill S, et al. Transgenic and knockout analyses of the role of TNF in immune regulation and disease pathogenesis. J Inflamm. 1995;47:27\u201338.","journal-title":"J Inflamm"},{"key":"2327_CR20","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1002\/eji.1830271018","volume":"27","author":"L Alexopoulou","year":"1997","unstructured":"Alexopoulou L, Pasparakis M, Kollias G. A murine transmembrane tumor necrosis factor (TNF) transgene induces arthritis by cooperative p55\/p75 TNF receptor signaling. Eur J Immunol. 1997;27:2588\u201392.","journal-title":"Eur J Immunol"},{"key":"2327_CR21","first-page":"926","volume":"77","author":"L Ntari","year":"2018","unstructured":"Ntari L, Sakkou M, Chouvardas P, Mourouzis I, Prados A, Denis MC, et al. Comorbid TNF-mediated heart valve disease and chronic polyarthritis share common mesenchymal cell-mediated aetiopathogenesis. Ann Rheum Dis. 2018;77:926\u201334.","journal-title":"Ann Rheum Dis"},{"key":"2327_CR22","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1359\/JBMR.040205","volume":"19","author":"B G\u00f6rtz","year":"2004","unstructured":"G\u00f6rtz B, Hayer S, Redlich K, Zwerina J, Tohidast-Akrad M, Tuerk B, et al. Arthritis induces lymphocytic bone marrow inflammation and endosteal bone formation. J Bone Min Res. 2004;19:990\u20138.","journal-title":"J Bone Min Res"},{"key":"2327_CR23","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1016\/j.humpath.2007.02.009","volume":"38","author":"K Engels","year":"2007","unstructured":"Engels K, Oeschger S, Hansmann ML, Hillebrand M, Kriener S. Bone marrow trephines containing lymphoid aggregates from patients with rheumatoid and other autoimmune disorders frequently show clonal B-cell infiltrates. Hum Pathol. 2007;38:1402\u201311.","journal-title":"Hum Pathol"},{"key":"2327_CR24","doi-asserted-by":"crossref","unstructured":"Kaaij MH, van Tok MN, Blijdorp IC, Ambarus CA, Stock M, Pots D, et al. Transmembrane TNF drives osteoproliferative joint inflammation reminiscent of human spondyloarthritis. J Exp Med. 2020;217(10):e20200288.","DOI":"10.1084\/jem.20200288"},{"key":"2327_CR25","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3389\/fimmu.2019.00382","volume":"10","author":"S Menegatti","year":"2019","unstructured":"Menegatti S, Bianchi E, Rogge L. Anti-TNF therapy in spondyloarthritis and related diseases, impact on the immune system and prediction of treatment responses. Front Immunol. 2019;10:382.","journal-title":"Front Immunol"},{"key":"2327_CR26","doi-asserted-by":"publisher","first-page":"8521","DOI":"10.2147\/IJN.S216199","volume":"14","author":"Y Xi","year":"2019","unstructured":"Xi Y, Jiang T, Chaurasiya B, Zhou Y, Yu J, Wen J, et al. Advances in nanomedicine for the treatment of ankylosing spondylitis. Int J Nanomedicine. 2019;14:8521\u201342.","journal-title":"Int J Nanomedicine"},{"key":"2327_CR27","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.3389\/fimmu.2018.02668","volume":"9","author":"A Watad","year":"2018","unstructured":"Watad A, Bridgewood C, Russell T, Marzo-Ortega H, Cuthbert R, McGonagle D. The early phases of ankylosing spondylitis: emerging insights from clinical and basic science. Front Immunol. 2018;9:2668.","journal-title":"Front Immunol"},{"key":"2327_CR28","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/ar592","volume":"4","author":"J Braun","year":"2002","unstructured":"Braun J, Sieper J. Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-\u03b1 therapy and other novel approaches. Arthritis Res. 2002;4:307\u201321.","journal-title":"Arthritis Res"},{"key":"2327_CR29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s13244-010-0061-4","volume":"2","author":"AG Jurik","year":"2011","unstructured":"Jurik AG. Imaging the spine in arthritis\u2014a pictorial review. Insights Imaging. 2011;2:177\u201391.","journal-title":"Insights Imaging"},{"key":"2327_CR30","doi-asserted-by":"publisher","first-page":"318","DOI":"10.21037\/qims.2018.11.10","volume":"9","author":"C Tsoi","year":"2019","unstructured":"Tsoi C, Griffith JF, Lee RKL, Wong PCH, Tam LS. Imaging of sacroiliitis: current status, limitations and pitfalls. Quant Imaging Med Surg. 2019;9:318\u201335.","journal-title":"Quant Imaging Med Surg"},{"key":"2327_CR31","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/art.23260","volume":"58","author":"J Sieper","year":"2008","unstructured":"Sieper J, Appel H, Braun J, Rudwaleit M. Critical appraisal of assessment of structural damage in ankylosing spondylitis: implications for treatment outcomes. Arthritis Rheum. 2008;58:649\u201356.","journal-title":"Arthritis Rheum"},{"key":"2327_CR32","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1136\/annrheumdis-2013-203643","volume":"73","author":"P Jacques","year":"2014","unstructured":"Jacques P, Lambrecht S, Verheugen E, Pauwels E, Kollias G, Armaka M, et al. Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells. Ann Rheum Dis. 2014;73:437\u201345.","journal-title":"Ann Rheum Dis"},{"key":"2327_CR33","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1136\/ard.2008.091074","volume":"68","author":"M Benjamin","year":"2009","unstructured":"Benjamin M, Toumi H, Suzuki D, Hayashi K, McGonagle D. Evidence for a distinctive pattern of bone formation in enthesophytes. Ann Rheum Dis. 2009;68:1003\u201310.","journal-title":"Ann Rheum Dis"},{"key":"2327_CR34","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1177\/147323000102900603","volume":"29","author":"T Kawakami","year":"2001","unstructured":"Kawakami T, Kawai T, Kimura A, Hasegawa H, Tsujigiwa H, Gunduz M, et al. Characteristics of bone morphogenetic protein-induced chondroid bone: histochemical, immunohistochemical and in situ hybridization examinations. J Int Med Res. 2001;29:480\u20137.","journal-title":"J Int Med Res"},{"key":"2327_CR35","doi-asserted-by":"crossref","unstructured":"Lai Y, Zhang Y, Mo S, Ma J, Ni T, Lei Z, et al. Prevalence of comorbidities and risk factors in spondyloarthritis: results of a cross-sectional study. Ann Rheum Dis. 2020..","DOI":"10.1136\/annrheumdis-2020-217313"},{"key":"2327_CR36","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.3899\/jrheum.170051","volume":"44","author":"GE Fitzgerald","year":"2017","unstructured":"Fitzgerald GE, O\u2019Shea FD. The fascinating paradox of osteoporosis in axial spondyloarthropathy. J Rheumatol. 2017;44:1767\u201376.","journal-title":"J Rheumatol"},{"key":"2327_CR37","doi-asserted-by":"publisher","first-page":"A9","DOI":"10.1136\/annrheumdis-2013-203215.15","volume":"72","author":"LM van Duivenvoorde","year":"2013","unstructured":"van Duivenvoorde LM, Ambarus CA, Masdar H, van Tok MN, Tak PP, Yeremenko NG, et al. A2.15 relative overexpression of Ttansmembrane versus soluble TNF in human and experimental spondyloarthritis. Ann Rheum Dis. 2013;72:A9\u201310.","journal-title":"Ann Rheum Dis"},{"key":"2327_CR38","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.4049\/jimmunol.175.4.2438","volume":"175","author":"MJ Turner","year":"2005","unstructured":"Turner MJ, Sowders DP, DeLay ML, Mohapatra R, Bai S, Smith JA, et al. HLA-B27 Misfolding in transgenic rats is associated with activation of the unfolded protein response. J Immunol. 2005;175:2438\u201348.","journal-title":"J Immunol"},{"key":"2327_CR39","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1002\/art.38638","volume":"66","author":"H Benham","year":"2014","unstructured":"Benham H, Rehaume LM, Hasnain SZ, Velasco J, Baillet AC, Ruutu M, et al. Interleukin-23 mediates the intestinal response to microbial \u03b2-1,3-glucan and the development of spondyloarthritis pathology in SKG mice. Arthritis Rheumatol. 2014;66:1755\u201367.","journal-title":"Arthritis Rheumatol"},{"key":"2327_CR40","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/s41584-019-0294-7","volume":"15","author":"J Sieper","year":"2019","unstructured":"Sieper J, Poddubnyy D, Miossec P. The IL-23\u2013IL-17 pathway as a therapeutic target in axial spondyloarthritis. Nat Rev Rheumatol. 2019;15:747\u201357.","journal-title":"Nat Rev Rheumatol"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-020-02327-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-020-02327-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-020-02327-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T03:54:49Z","timestamp":1633492489000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-020-02327-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,6]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2327"],"URL":"https:\/\/doi.org\/10.1186\/s13075-020-02327-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.05.14.095588","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-27344\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-27344\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-27344\/v2","asserted-by":"object"}]},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,6]]},"assertion":[{"value":"5 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was carried out in accordance with the recommendations of Institutional Committee of Protocol Evaluation in conjunction with the Veterinary Service Management of the Hellenic Republic Prefecture of Attika (Approval No.141688 24\/04\/19) and in accordance to national legislation and the European Union Directive 63\/2010.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"GK participates in the BoD of Biomedcode; FM has received grants from Pfizer. All other authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"232"}}